The Nephrotoxicity of Drugs Used in Causal Oncological Therapies.

In recent years, a dynamic development of oncology has been observed, resulting from the increasingly frequent occurrence of neoplasms and therefore, increasing population of patients. The most effective form of therapy for cancer patients is complex multidisciplinary specialized disease management, including nephro-oncology care. Different forms of renal function impairment are frequently diagnosed in cancer patients.

Continuous renal replacement therapy as a treatment of selected acute intoxications.

The methods of extracorporeal elimination remain a particularly useful therapy of selected, most severe intoxications caused by drugs and other chemical substances. The hemodialysis (HD) is the most commonly used therapy, which results from the widest availability of this method. However, due to the gradual spread of modern continuous dialysis techniques, continuous veno-venous hemodialysis (CVVHD) in particular creates a new opportunity of treatment of severe intoxications - especially in patients with cardiovascular complications.

[Sepsis - still valid economic and epidemiological problem].

The recognition of sepsis is connected with potentially bad prognosis, high mortality rate and high costs of the therapy. A new definition of sepsis was introduced in 2016. The main role of dysfunction of organs in the course of infection, the potential threat for life and necessity to perform quick diagnosis result from this definition.

Changes of peritoneal transport parameters with time on dialysis: assessment with sequential peritoneal equilibration test.

Background: Sequential peritoneal equilibration test (sPET) is based on the consecutive performance of the peritoneal equilibration test (PET, 4-hour, glucose 2.27%) and the mini-PET (1-hour, glucose 3.86%), and the estimation of peritoneal transport parameters with the 2-pore model.

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients.

During peritoneal dialysis (PD), the peritoneal membrane undergoes ageing processes that affect its function. Here we analyzed associations of patient age and dialysis vintage with parameters of peritoneal transport of fluid and solutes, directly measured and estimated based on the pore model, for individual patients. Thirty-three patients (15 females; age 60 (21-87) years; median time on PD 19 (3-100) months) underwent sequential peritoneal equilibration test.